Neurocrine Biosciences, Inc.Neurocrine Biosciences, Inc.Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪13.26 B‬USD
‪249.70 M‬USD
‪1.89 B‬USD
‪96.92 M‬
Beta (1Y)
0.57

About Neurocrine Biosciences, Inc.

CEO
Kevin Charles Gorman
Headquarters
San Diego
Employees (FY)
‪1.4 K‬
Founded
1992
ISIN
US64125C1099
FIGI
BBG000GJS7C1
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where NBIX is featured.

Frequently Asked Questions

The current price of NBIX is 133.23 USD — it has increased by 0.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Neurocrine Biosciences, Inc. stocks are traded under the ticker NBIX.
Neurocrine Biosciences, Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
NBIX stock is 2.34% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is Neurocrine Biosciences, Inc. there?
One year price forecast for Neurocrine Biosciences, Inc. has a max estimate of 200.00 USD and a min estimate of 106.00 USD.
NBIX earnings for the last quarter are 0.82 USD whereas the estimation was 1.04 USD which accounts for −21.11% surprise. Estimated earnings for the next quarter are 1.21 USD. See more details about Neurocrine Biosciences, Inc. earnings.
Neurocrine Biosciences, Inc. revenue for the last quarter amounts to ‪498.80 M‬ USD despite the estimated figure of ‪479.09 M‬ USD. In the next quarter revenue is expected to reach ‪518.52 M‬ USD.
Yes, you can track Neurocrine Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
NBIX stock has fallen by 3.77% compared to the previous week, the month change is a 4.32% fall, over the last year Neurocrine Biosciences, Inc. has showed a 28.28% increase.
NBIX net income for the last quarter is ‪147.70 M‬ USD, while the quarter before that showed ‪83.10 M‬ USD of net income which accounts for 77.74% change. Track more Neurocrine Biosciences, Inc. financial stats to get the full picture.
Today Neurocrine Biosciences, Inc. has the market capitalization of ‪13.26 B‬, it has increased by 1.23% over the last week.
No, NBIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NBIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neurocrine Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
NBIX reached its all-time high on Mar 21, 2024 with the price of 148.37 USD, and its all-time low was 1.94 USD and was reached on Nov 30, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.40 K‬ employees. See our rating of the largest employees — is Neurocrine Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Neurocrine Biosciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Neurocrine Biosciences, Inc. stock shows the buy signal. See more of Neurocrine Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Neurocrine Biosciences, Inc. future price: according to them, NBIX price has a max estimate of 200.00 USD and a min estimate of 106.00 USD. Read a more detailed Neurocrine Biosciences, Inc. forecast: see what analysts think of Neurocrine Biosciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Neurocrine Biosciences, Inc. EBITDA is ‪416.10 M‬ USD, and current EBITDA margin is 22.05%. See more stats in Neurocrine Biosciences, Inc. financial statements.